Literature DB >> 28954888

Type III IFNs Are Commonly Induced by Bacteria-Sensing TLRs and Reinforce Epithelial Barriers during Infection.

Charlotte Odendall1,2,3, Andrew A Voak3, Jonathan C Kagan1,2.   

Abstract

Type III IFNs (IFN-λs) are secreted factors that are well-known for their antiviral activities. However, their regulation and functions during bacterial infections are unclear. In this article, we report that the regulation of IFN-λ genes did not track with mechanisms that control type I IFN expression in response to TLRs. Whereas type I IFNs were only expressed from TLRs present on endosomes, type III IFNs could be induced by TLRs that reside at the plasma membrane and that detect various bacterial products. The mechanisms that regulate type III IFN gene expression tracked with those that promote inflammatory cytokine and chemokine expression. Importantly, rIFN-λs enhanced epithelial barriers in vitro, preventing transcellular bacteria dissemination. We therefore propose that in addition to their functions in cell-intrinsic antiviral immunity, type III IFNs protect epithelial barrier integrity, an activity that would benefit the host during any infectious encounter.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28954888      PMCID: PMC5679450          DOI: 10.4049/jimmunol.1700250

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  54 in total

Review 1.  Toll-like receptor control of the adaptive immune responses.

Authors:  Akiko Iwasaki; Ruslan Medzhitov
Journal:  Nat Immunol       Date:  2004-10       Impact factor: 25.606

2.  Viral infections activate types I and III interferon genes through a common mechanism.

Authors:  Kazuhide Onoguchi; Mitsutoshi Yoneyama; Azumi Takemura; Shizuo Akira; Tadatsugu Taniguchi; Hideo Namiki; Takashi Fujita
Journal:  J Biol Chem       Date:  2007-01-04       Impact factor: 5.157

3.  Role of the p38 MAPK signaling pathway in mediating interleukin-28A-induced migration of UMUC-3 cells.

Authors:  Se-Jung Lee; Wun-Jae Kim; Sung-Kwon Moon
Journal:  Int J Mol Med       Date:  2012-07-16       Impact factor: 4.101

4.  Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3.

Authors:  Rashu B Seth; Lijun Sun; Chee-Kwee Ea; Zhijian J Chen
Journal:  Cell       Date:  2005-09-09       Impact factor: 41.582

Review 5.  SMOCs: supramolecular organizing centres that control innate immunity.

Authors:  Jonathan C Kagan; Venkat Giri Magupalli; Hao Wu
Journal:  Nat Rev Immunol       Date:  2014-10-31       Impact factor: 53.106

6.  Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling.

Authors:  Su-Chang Lin; Yu-Chih Lo; Hao Wu
Journal:  Nature       Date:  2010-05-19       Impact factor: 49.962

7.  Salmonella Interaction with and Passage through the Intestinal Mucosa: Through the Lens of the Organism.

Authors:  Kelly Hallstrom; Beth A McCormick
Journal:  Front Microbiol       Date:  2011-04-29       Impact factor: 5.640

8.  IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo.

Authors:  Caroline Sommereyns; Sophie Paul; Peter Staeheli; Thomas Michiels
Journal:  PLoS Pathog       Date:  2008-03-14       Impact factor: 6.823

9.  Diverse intracellular pathogens activate type III interferon expression from peroxisomes.

Authors:  Charlotte Odendall; Evelyn Dixit; Fabrizia Stavru; Helene Bierne; Kate M Franz; Ann Fiegen Durbin; Steeve Boulant; Lee Gehrke; Pascale Cossart; Jonathan C Kagan
Journal:  Nat Immunol       Date:  2014-06-22       Impact factor: 25.606

10.  Comprehensive RNAi-based screening of human and mouse TLR pathways identifies species-specific preferences in signaling protein use.

Authors:  Jing Sun; Ning Li; Kyu-Seon Oh; Bhaskar Dutta; Sharat J Vayttaden; Bin Lin; Thomas S Ebert; Dominic De Nardo; Joie Davis; Rustam Bagirzadeh; Nicolas W Lounsbury; Chandrashekhar Pasare; Eicke Latz; Veit Hornung; Iain D C Fraser
Journal:  Sci Signal       Date:  2016-01-05       Impact factor: 8.192

View more
  39 in total

1.  Meeting Overview: Interferon Lambda-Disease Impact and Therapeutic Potential.

Authors:  Thomas R O'Brien; Howard A Young; Raymond P Donnelly; Ludmila Prokunina-Olsson
Journal:  J Interferon Cytokine Res       Date:  2019-04-17       Impact factor: 2.607

2.  Interferon Lambda: An Immune System Factor That Cancer Epidemiologists Should Consider.

Authors:  Danielle Mercatante Carrick
Journal:  J Interferon Cytokine Res       Date:  2019-03-20       Impact factor: 2.607

Review 3.  Interferon Lambda's New Role as Regulator of Neutrophil Function.

Authors:  Amariliz Rivera
Journal:  J Interferon Cytokine Res       Date:  2019-04-23       Impact factor: 2.607

4.  Innate IFN-lambda responses to dsRNA in the human infant airway epithelium and clinical regulatory factors during viral respiratory infections in early life.

Authors:  Kyle Salka; Maria Arroyo; Elizabeth Chorvinsky; Karima Abutaleb; Geovanny F Perez; Seth Wolf; Xilei Xuchen; Jered Weinstock; Maria J Gutierrez; Marcos Pérez-Losada; Dinesh K Pillai; Gustavo Nino
Journal:  Clin Exp Allergy       Date:  2020-07-26       Impact factor: 5.018

Review 5.  Type III IFNs: Beyond antiviral protection.

Authors:  Sergei V Kotenko; Amariliz Rivera; Dane Parker; Joan E Durbin
Journal:  Semin Immunol       Date:  2019-06       Impact factor: 11.130

Review 6.  Shared and Distinct Functions of Type I and Type III Interferons.

Authors:  Helen M Lazear; John W Schoggins; Michael S Diamond
Journal:  Immunity       Date:  2019-04-16       Impact factor: 31.745

Review 7.  Innate immune sensing by epithelial barriers.

Authors:  David A Constant; Timothy J Nice; Isabella Rauch
Journal:  Curr Opin Immunol       Date:  2021-08-13       Impact factor: 7.486

Review 8.  Protective and Pathogenic Effects of Interferon Signaling During Pregnancy.

Authors:  Rebecca L Casazza; Helen M Lazear; Jonathan J Miner
Journal:  Viral Immunol       Date:  2019-09-23       Impact factor: 2.257

Review 9.  Interferon-λ orchestrates innate and adaptive mucosal immune responses.

Authors:  Liang Ye; Daniel Schnepf; Peter Staeheli
Journal:  Nat Rev Immunol       Date:  2019-06-14       Impact factor: 53.106

10.  Critical role of interferons in gastrointestinal injury repair.

Authors:  Constance McElrath; Vanessa Espinosa; Jian-Da Lin; Jianya Peng; Raghavendra Sridhar; Orchi Dutta; Hsiang-Chi Tseng; Sergey V Smirnov; Heidi Risman; Marvin J Sandoval; Viralkumar Davra; Yun-Juan Chang; Brian P Pollack; Raymond B Birge; Mark Galan; Amariliz Rivera; Joan E Durbin; Sergei V Kotenko
Journal:  Nat Commun       Date:  2021-05-11       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.